CSIMarket
 


Biotricity Inc   (BTCY)
Other Ticker:  
 

Biotricity Inc 's Working Capital Ratio

BTCY's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Working Capital Ratio fell to 0.21 below Biotricity Inc average.

Within Medical Equipment & Supplies industry 165 other companies have achieved higher Working Capital Ratio than Biotricity Inc in third quarter 2023. While Working Capital Ratio total ranking has improved so far during the III Quarter 2023 to 3863, from total ranking in the first quarter 2023 at 4517.

Explain Working Capital Ratio
How much in Current Assets BTCY´s has?
What is the value of BTCY´s Current Liabilities?


BTCY Working Capital Ratio (Dec 31 2023)
III. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
(Sep 30 2022)
II. Quarter
Y / Y Current Liabilities Change 324.24 % 229.83 % 129.33 % 50.98 % -15.83 %
Y / Y Current Assets Change -41.76 % -59.43 % -69.19 % -75.55 % -51.59 %
Working Capital Ratio MRQ 0.21 0.29 0.42 0.66 1.54
BTCY's Total Ranking # 3863 # 4517 # 4352 # 3838 #
Seq. Current Liabilities Change 23.32 % 35.27 % 53.08 % 66.12 % -4.12 %
Seq. Current Assets Change -10.64 % -6.77 % -1.55 % -28.99 % -37.75 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 166
Healthcare Sector # 697
Overall Market # 3863


Working Capital Ratio Statistics
High Average Low
4.06 0.82 0.02
(Dec 31 2021)   (Dec 31 2016)




Financial Statements
Biotricity Inc 's Current Liabilities $ 19 Millions Visit BTCY's Balance sheet
Biotricity Inc 's Current Assets $ 4 Millions Visit BTCY's Balance sheet
Source of BTCY's Sales Visit BTCY's Sales by Geography


Cumulative Biotricity Inc 's Working Capital Ratio

BTCY's Working Capital Ratio for the trailling 12 Months

BTCY Working Capital Ratio

(Dec 31 2023)
III. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
(Sep 30 2022)
II. Quarter
Y / Y Current Liabilities TTM Growth 324.24 % 229.83 % 129.33 % 50.98 % -15.83 %
Y / Y Current Assets TTM Growth -41.76 % -59.43 % -69.19 % -75.55 % -51.59 %
Working Capital Ratio TTM 0.34 0.54 0.99 1.79 2.81
Total Ranking TTM # 853 # 4226 # 4148 # 440 #
Seq. Current Liabilities TTM Growth 23.32 % 35.27 % 53.08 % 66.12 % -4.12 %
Seq. Current Assets TTM Growth -10.64 % -6.77 % -1.55 % -28.99 % -37.75 %


On the trailing twelve months basis Due to growth in Current Liabilities in the III Quarter 2023 to $18.62 millions, cumulative Working Capital Ratio decreased to 0.34 below the Biotricity Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 41 other companies have achieved higher Working Capital Ratio than Biotricity Inc . While Working Capital Ratio overall ranking has improved so far to 853, from total ranking during the twelve months ending first quarter 2023 at 4226.

Explain Working Capital Ratio
How much in Current Assets BTCY´s has?
What is the value of BTCY´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 42
Healthcare Sector # 129
Within the Market # 853


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.06 0.89 0.17
(Jun 30 2022)   (Sep 30 2019)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2023 MRQ Current AssetsDec 31 2023 MRQ Current Liabilities
Intelligent Bio Solutions Inc   0.57 $ 2.945  Millions$ 5.183  Millions
P3 Health Partners Inc   0.55 $ 166.017  Millions$ 299.372  Millions
Pavmed Inc   0.47 $ 24.498  Millions$ 52.612  Millions
Vivos Therapeutics Inc   0.34 $ 2.461  Millions$ 7.289  Millions
Assure Holdings Corp   0.30 $ 6.723  Millions$ 22.218  Millions
Guided Therapeutics Inc   0.29 $ 1.393  Millions$ 4.809  Millions
Non Invasive Monitoring Systems Inc  0.28 $ 0.101  Millions$ 0.355  Millions
Yubo International Biotech Limited  0.21 $ 0.725  Millions$ 3.395  Millions
Biotricity Inc   0.21 $ 3.932  Millions$ 18.619  Millions
Nemaura Medical Inc   0.20 $ 4.372  Millions$ 21.461  Millions
Arch Therapeutics Inc   0.16 $ 1.814  Millions$ 11.398  Millions
Invo Bioscience Inc   0.15 $ 1.260  Millions$ 8.219  Millions
Sanuwave Health Inc   0.15 $ 9.784  Millions$ 64.755  Millions
Vycor Medical Inc   0.14 $ 0.590  Millions$ 4.075  Millions
Electromedical Technologies inc   0.13 $ 0.449  Millions$ 3.357  Millions
Neuraxis Inc   0.13 $ 0.243  Millions$ 1.828  Millions
Biosig Technologies Inc   0.12 $ 0.528  Millions$ 4.582  Millions
United Health Products Inc   0.08 $ 0.152  Millions$ 1.950  Millions
Qhslab Inc   0.08 $ 0.156  Millions$ 2.057  Millions
Altair International Corp   0.06 $ 0.017  Millions$ 0.279  Millions
Holdco Nuvo Group D g Ltd   0.05 $ 1.577  Millions$ 30.945  Millions
Odyssey Health Inc   0.05 $ 0.259  Millions$ 5.380  Millions
Marizyme Inc   0.05 $ 0.969  Millions$ 20.603  Millions
Therapeutic Solutions International Inc   0.05 $ 0.086  Millions$ 1.900  Millions

Date modified: 2024-02-21T12:13:39+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com